ATGL Deficiency-Induced Triglyceride Deposit Cardiomyovasculopathy Requiring Heart Transplant: A 5-Year Follow-Up.

ATGL, adipose triglyceride lipase CK, creatine kinase CMR, cardiac magnetic resonance EMB, endomyocardial biopsy PNPLA2, patatin-like phospholipase domain containing 2 cardiac magnetic resonance cardiac transplant cardiomyopathy chronic heart failure genetic disorders lipid metabolism disorders

Journal

JACC. Case reports
ISSN: 2666-0849
Titre abrégé: JACC Case Rep
Pays: Netherlands
ID NLM: 101757292

Informations de publication

Date de publication:
May 2020
Historique:
received: 17 03 2020
accepted: 26 03 2020
entrez: 28 7 2021
pubmed: 20 5 2020
medline: 20 5 2020
Statut: epublish

Résumé

A young man presented with syncope. He was diagnosed with triglyceride deposit cardiomyovasculopathy and skeletal myopathy secondary to adipose triglyceride lipase (ATGL) deficiency. Despite optimal medical therapy, he required heart transplantation to treat his heart failure. Five years post-transplant, the graft function was normal with no evidence of triglyceride deposits. (

Identifiants

pubmed: 34317343
doi: 10.1016/j.jaccas.2020.03.021
pii: S2666-0849(20)30347-8
pmc: PMC8302057
doi:

Types de publication

Case Reports

Langues

eng

Pagination

760-763

Informations de copyright

© 2020 The Authors.

Références

J Neurol. 2011 Nov;258(11):1987-97
pubmed: 21544567
Mol Genet Metab. 2015 Jun-Jul;115(2-3):110-7
pubmed: 25956450
Nat Genet. 2007 Jan;39(1):28-30
pubmed: 17187067
Int J Cardiol. 2016 Mar 15;207:165-7
pubmed: 26803235
PLoS Genet. 2010 Dec 09;6(12):e1001239
pubmed: 21170305
Orphanet J Rare Dis. 2019 Oct 26;14(1):234
pubmed: 31655616
Nat Med. 2011 Aug 21;17(9):1076-85
pubmed: 21857651
Biochem Biophys Res Commun. 2014 Jan 10;443(2):574-9
pubmed: 24332944
Science. 2004 Nov 19;306(5700):1383-6
pubmed: 15550674

Auteurs

Prina Rajani (P)

Heart Transplant Department, Royal Brompton and Harefield NHS Foundation Trust, Oxford, United Kingdom.

Jan Lukas Robertus (JL)

Heart Transplant Department, Royal Brompton and Harefield NHS Foundation Trust, Oxford, United Kingdom.

Joyce Wong (J)

Heart Transplant Department, Royal Brompton and Harefield NHS Foundation Trust, Oxford, United Kingdom.

Tessa Homfray (T)

Heart Transplant Department, Royal Brompton and Harefield NHS Foundation Trust, Oxford, United Kingdom.

Fernando Riesgo Gil (FR)

Heart Transplant Department, Royal Brompton and Harefield NHS Foundation Trust, Oxford, United Kingdom.

Mayooran Shanmuganathan (M)

Heart Transplant Department, Royal Brompton and Harefield NHS Foundation Trust, Oxford, United Kingdom.
Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom.

Classifications MeSH